Panel 1

About

Dato Dr Kim Tan PhD

Chairman of SpringHill Management, a private fund management company specialising in biotech and social venture capital investments. He is a partner and advisor to a number of impact funds including Springhill Equity Partners (US), Inqo (SA), Novastar Ventures (Kenya), Truestone Impact Investment Fund (UK) and Garden Impact Investment (Singapore). He is the co-founder of the Transformational Business Network and is on the advisory boards of the John Templeton Foundation, Johnson & Johnson Citizenship Trust and PovertyCure. He is a board member of the Centre for Enterprise, Markets & Ethics (Oxford) and the APEC Life Science Innovation Forum. He was the founder chairman of the Nilai Cancer Hospital (Malaysia) and a board member of the Saracens Rugby Club (UK). He is a Pro-Chancellor of the University of Surrey (UK), the inventor of sheep monoclonal antibodies and a Fellow of the Royal Society of Medicine (UK).

Panel 2

Funds

inqo_logo234x91
Inqo Investments
Novostar_logo234x91
Novastar Ventures
Springhill_logo234x91
Springhill Equity Partners
garden_logo234x91
Garden Impact Investmetns

 

Panel 3

Holdings

saracens_logo250x100
Saracens Rugby

bioventix_logo250x100
Bioventix Plc

 

Nilai250x100
Nilai Medical Centre

Marksan_logo250x100
Marksans Pharma Ltd.

Panel 4

Associated Organisations

ceme_logo250x100
The Centre for Enterprise, Markets and Ethics
tbn_logo250x100
The Transformational Business Network
surrey250x100
University of Surrey
JJ250x100
Johnson and Johnson Citizenship Trust
tbn_asia250x100
Transformational Business Network Asia